These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28792134)

  • 21. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer.
    Stiksma J; Grootendorst DC; van der Linden PW
    Clin Colorectal Cancer; 2014 Dec; 13(4):239-44. PubMed ID: 25442815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study.
    Moon CM; Jung SA; Eun CS; Park JJ; Seo GS; Cha JM; Park SC; Chun J; Lee HJ; Jung Y; Boo SJ; Kim JO; Joo YE; Park DI
    Dig Liver Dis; 2018 Aug; 50(8):847-852. PubMed ID: 29730157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
    Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
    Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different risk factors for advanced colorectal neoplasm in young adults.
    Kim JY; Jung YS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Choi KY; Park DI
    World J Gastroenterol; 2016 Apr; 22(13):3611-20. PubMed ID: 27053853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
    Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
    Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic yield of advanced colorectal neoplasia at colonoscopy, according to indications: an investigation from the Korean Association for the Study of Intestinal Diseases (KASID).
    Park DI; Kim YH; Kim HS; Kim WH; Kim TI; Kim HJ; Yang SK; Byeon JS; Lee MS; Jung IK; Chung MK; Jung SA; Jeen YT; Choi JH; Choi H; Han DS; Song JS
    Endoscopy; 2006 May; 38(5):449-55. PubMed ID: 16767578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
    Zhang D; Yu M; Xu T; Xiong B
    Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
    Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
    Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative tissue carcinoembryonic antigen (T CEA) assay as a screening test for severe dysplasia in colorectal adenomas.
    Rosandić M; Skegro M; Paar V; Paar D; Sćukanec-Spoljar M; Juricić M; Vucelić B; Pulanić R; Rustemović N; Ostojić R; Ljubojević N
    Acta Med Austriaca; 1999; 26(3):89-92. PubMed ID: 10520376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history of gastric cancer is associated with the risk of colorectal neoplasia in Korean population.
    Jung YS; Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2017 Oct; 49(10):1155-1161. PubMed ID: 28801179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.